Article
Heart Failure in Relation to Anthracyclines and Other Chemotherapies.
Methodist DeBakey cardiovascular journal - 1 Jan 2000
Agunbiade Tolulope A, Zaghlol Raja Y, Barac Ana
Abstract excerpt
Anthracyclines are the cornerstone of therapy for a wide range of solid and hematologic malignancies; however, their use is limited by the risk of chemotherapy-induced cardiotoxicity leading to cardiomyopathy and heart failure. The incidence of cardiotoxicity in the literature depends on the definition being used, anthracycline dose, duration of follow-up, and surveillance methods used to identify cardiac injury....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.